Intelligent Bio Solutions (INBS) Current Deferred Tax Assets (2020 - 2023)
Intelligent Bio Solutions (INBS) recorded quarterly Current Deferred Tax Assets of $34100.0 in Q2 2023, down 88.63% quarter-over-quarter from $300000.0 in Q3 2022.
Intelligent Bio Solutions (INBS) Current Deferred Tax Assets (2020 - 2023) Analysis & Trends
Intelligent Bio Solutions' Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $34100.0 for Q2 2023.
- In Q2 2023, Current Deferred Tax Assets changed N/A year-over-year to $34100.0; the TTM figure through Jun 2023 stood at $34100.0 (changed N/A YoY), while the FY2023 annual figure was $34100.0, changed N/A from the prior year.
- Current Deferred Tax Assets was $34100.0 for Q2 2023 at Intelligent Bio Solutions, down from $300000.0 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $1.9 million in Q2 2020 to a low of $34100.0 in Q2 2023.
- Historically, Current Deferred Tax Assets has averaged $732571.0 across 3 years, with a median of $300000.0 in 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 34,100.00 |
| Jun 30, 2023 | 34,100.00 |
| Sep 30, 2022 | 300,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2020 | 1.86 Mn |
| Jun 30, 2020 | 1.86 Mn |